Furthermore, the mithralog did not alter the immune production of key antitumor effector molecules (IFN-γ and perforin), suggesting that EC-7072 does not exacerbate the immune dysregulation frequently observed in patients with CLL. The gene discussed is PRF1; the disease is B-cell chronic lymphocytic leukemia.